Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including...
angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01, its lead clinical-stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. ACP-01 is in a Phase 2 clinical trial in Canada and the United States. Its technology includes methods for collecting the synergetic cell population and manufacturing a personalized regenerative therapy that can be administered to a patient within seven days of the initial cell collection. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd. and PreCerv Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Post by
RamboOO7
on Jun 13, 2022 4:50pm
Still waiting.. When i see volume rising i might hop in
GLTA
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 13, 2022 12:44pm
Hemostemix Inc. Market Insights
Hemostemix Inc. is a publicly-traded biotech company, with the ticker symbol as $HMTXF, listed on the OTC Market, having a reasonable market cap of 16M, marked a open today $0.2234.
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project
posted May 01, 2024 9:00am by
Viva Gold Corp.
-
|
Previously unknown areas of gold mineralization were discovered with longer lengths and higher gold grades than expected. 21.3 meters at 5.1 gpt Au was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40-meters depth). James Hesketh, President & CEO stated, “Many geologists go their whole careers without seeing drill results like these ...read more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 13, 2022 12:24pm
Hemostemix Market Impression
The company deals with the CLI treatment which is specifically developing, manufacturing, and commercializing innovative blood-derived stem cell therapies. Listed on the OTC platform with $HMTXF as
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 13, 2022 12:13pm
Hemostemix Inc. stock updates
Hemostemix Inc., (OTCQB: $HMTXF) is a Canada-based biotech company, listed on the OTC Market with the ticker symbol as $HMTXF, having a decent market cap 16M, marked a open today at $0.2234.
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 13, 2022 12:07pm
The closure of convertible debenture
Hemostemix closed the previously released convertible debenture offering the $1,000 principal amount of each offering. https://www.newsfilecorp.com/redirect/PMjmQc7qye
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 13, 2022 11:51am
Hemostemix market value
$HMTXF holding its ground amid price fluctuation with an incredible market cap of 16 million+.
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 10, 2022 3:05pm
Hemostemix information regarding intellectual property
Hemostemix Inc. recently announced the settlement of all litigation with aspire Health Service Inc., AJIA Global, LLC and Alan Jacobs, Jed Wood, Randi Wood, Blake Wood, Kyle Makofka, Reginald
...more
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Comment by
RamboOO7
on Jun 10, 2022 2:55pm
RE:RE:RE:Wow no volume !
Thanks for the heads up
(36)
•••
WalterTheDawg
X
View Profile
View Bullboard History
Comment by
WalterTheDawg
on Jun 10, 2022 2:27pm
RE:RE:Wow no volume !
Holding pretty steady. I think we'll go up some once this PP closes and they give us an update on trial data and when we can expect results. Someone said PP should close next Friday
(9)
•••
JocetooBad
X
View Profile
View Bullboard History
Comment by
JocetooBad
on Jun 10, 2022 1:59pm
RE:Wow no volume !
people are waiting for news. No volume also means no sellers.
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Post by
RamboOO7
on Jun 10, 2022 1:55pm
Bcel just dropped.
I didn't buy any yet
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Post by
RamboOO7
on Jun 10, 2022 1:54pm
Wow no volume !
Looks like this will go down some. Still waiting !. Thought i missed the boat when it jumped to 37 cents awhile ago
(6)
•••
henery345
X
View Profile
View Bullboard History
Post by
henery345
on Jun 10, 2022 12:30pm
Hemostemix announce about closing of $2,750,000
Hemostemix Inc. has announced that it has closed its previously announced $2,750,000 non-brokered secured convertible debenture unit offering pursuant to which the Company issued 2,750 debenture units
...more
(6)
•••
henery345
X
View Profile
View Bullboard History
Post by
henery345
on Jun 10, 2022 12:21pm
$HMTXF get backs all its intellectual property
Hemostemix is now in possession of all of its intellectual property, including all HS 12-01 Phase II clinical trial data, all historical data from Hemostemix Israel, and the randomization tables that
...more
(6)
•••
henery345
X
View Profile
View Bullboard History
Post by
henery345
on Jun 10, 2022 12:16pm
Hemostemix owns over 91 patents
The Company owns 91 patents across five patent families titled: Regulating Stem Cells, In Vitro Techniques for use with Stem Cells, Production from Blood of Cells of Neural Lineage, and Automated Cell
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up